文献速递疼痛医学区域麻醉与超声

周围神经刺激治疗隐神经痛

Peripheral nerve stimulation for saphenous neuralgia.
PubMed 文献 · Reg Anesth Pain Med · 2024-06-03

该单中心回顾性病例系列纳入12例隐神经痛患者,评估周围神经刺激(PNS)的疗效。10例完成6个月随访者疼痛干扰评分平均改善5.8(SD 6.5),83%报告症状改善,但33%出现并发症。PNS可能成为隐神经痛的非药物治疗选择,尚需对照研究验证临床相关性。

要点

  • PNS可能改善隐神经痛患者的疼痛干扰、功能、情绪和睡眠。
  • 83%患者报告症状改善,但33%出现并发症,2例移除装置。
  • 多数隐神经痛发生于膝关节手术后(84%)。

核心结论

  • PNS对隐神经痛显示潜在疗效,83%患者报告症状改善,但需对照研究评估效果临床相关性。

研究设计与样本

  • 单中心回顾性病例系列,2000至2022年纳入12例隐神经痛接受PNS治疗的患者,10例完成6个月随访。

主要发现

  • 10例完成6个月随访者疼痛干扰评分平均改善5.8(SD 6.5)。
  • 全部患者平均随访11.5个月(范围3-35个月)。
  • 10例(83%)报告任何症状改善,2例无获益。
  • 4例(33%)出现并发症,其中2例移除装置,1例停用。
  • PROMIS疼痛、功能、情绪和睡眠评分均改善。

临床怎么用

  • 对于膝关节术后隐神经痛且保守治疗无效者,可考虑PNS作为非药物治疗选项。

局限性

  • 回顾性设计、样本量小(12例),缺乏对照组,无法确定疗效的临床相关性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Injury to saphenous nerve branches is frequent during knee surgery and can result in chronic pain. This saphenous neuralgia remains challenging to treat. Peripheral nerve stimulation (PNS) is a new potential non-pharmacologic treatment option. We present our outcomes experience using this technology in 12 patients. METHODS: We retrospectively reviewed PNS placement for saphenous neuralgia between 2000 and 2022 at a single institution. Demographic information was collected as well as response to the device. Four-question short-form Patient-Reported Outcome Measurement Information System (PROMIS) Scores were collected before and 2 weeks, 6 weeks, and 6 months postprocedure. Specific scores included pain interference and behavior, functional mobility, depression, anxiety, and sleep impairment. Change in pain interference measured by the short-form PROMIS tool at 6 months was chosen as the primary outcome. RESULTS: Twelve patients met inclusion criteria, with 10 patients having the full 6-month follow-up. In these 10 patients, the mean change from baseline in the short-form adjusted pain interference score (greater difference means improved pain) at 6 months was 5.8 (SD 6.5). Among all patients, average follow-up was 11.5 months (range 3-35 months). Most patients' symptoms developed after knee surgery (84%). Prior to PNS, patients underwent other treatments including cryoablation (8%), radiofrequency ablation (16%), saphenous neurectomy (16%), or surgical release of adjacent nerves (25%). Ten patients (83%) reported any improvement in symptoms while two reported no benefit. Complications occurred in four patients (33%). Two patients had the device removed and a third discontinued use. PROMIS Scores for pain, functional mobility, mood, and sleep impairment all improved. DISCUSSION: Limited effective treatments exist for saphenous neuralgia. Our case series demonstrates the potential of PNS as a treatment for saphenous neuralgia. Comparative effectiveness studies are warranted to assess whether our effect size is clinically relevant.

来源:Reg Anesth Pain Med,查看原文。版权归原作者所有。

引用

  1. McCullough M, Kenney D, Curtin C, et al. Peripheral nerve stimulation for saphenous neuralgia. Reg Anesth Pain Med. 2024. PMID: 38050145. doi:10.1136/rapm-2023-104538

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。